Apelin-13 vs Relaxin-2 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Apelin-13 is the most biologically active isoform of the apelin peptide family, endogenous ligands for the APJ receptor (also called APLNR). Apelin peptides are produced throughout the body, with the heart, lung, brain, and adipose tissue expressing particularly high levels....
Calculate Apelin-13 dose →Relaxin-2 (H2 Relaxin) is an endogenous peptide hormone of the insulin superfamily, best known for its roles in pregnancy physiology including cervical ripening, uterine quiescence, and connective tissue remodeling. Beyond reproduction, relaxin-2 is a systemic anti-fibrotic and v...
Calculate Relaxin-2 dose →| Parameter | Apelin-13 | Relaxin-2 |
|---|---|---|
| Category | Cardiovascular Peptide | Cardiovascular Peptide |
| Research | Clinical | Clinical |
| Half-Life | < 5 min (plasma) | 10-15 min (plasma) |
| Typical Dose | 50-300 nmol/kg | 30-300 mcg/kg/day (IV) |
| Frequency | Variable | Continuous 48-hour infusion (trials) |
| Route | Intravenous (research), Subcutaneous | Intravenous (infusion) |
| FDA Status | Not approved | Not approved (Phase III completed) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.